Sunwin Stevia International Inc (SUWN)
0.0003
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.0599M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -96.39% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.94% |
Profile
| Sunwin Stevia International Inc is engaged in the manufacture and sale of Stevia and its related products. It has two operating segments related to its product lines: Stevioside and Corporate and others. The majority of the revenue is generated from the Stevioside segment which produces and sells a variety of purified steviol glycosides with rebaudioside A and stevioside as the principal components. All of the company's operations are located in the People's Republic of China. |
| URL | https://www.sunwininternational.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Dec. 16, 2009 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Sunwin Stevia International Inc is engaged in the manufacture and sale of Stevia and its related products. It has two operating segments related to its product lines: Stevioside and Corporate and others. The majority of the revenue is generated from the Stevioside segment which produces and sells a variety of purified steviol glycosides with rebaudioside A and stevioside as the principal components. All of the company's operations are located in the People's Republic of China. |
| URL | https://www.sunwininternational.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Dec. 16, 2009 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |